Summit K12: The Power of Student Choice Reading Programs

Roni Burren, President of TCTELA, is a self-professed lover of books, children, and justice. She is a longtime K12 educator and current adjunct professor at the University of Houston. She spoke with JW Marshall about her role as president of the Texas Council of Teachers of English Language Arts and its focus on supporting ELA teachers through student choice reading initiatives.

In between year-round brainstorming conferences, the TCTELA recommends books for teaching reading at every level within K-12 classrooms. Supporting student choice in reading is an essential part of this work. Burren said the concepts on student reading have evolved, and telling students, ‘These are the books we’re reading,’ case closed is no longer the best teaching strategy.

“Over time, what people started to see was kids who became livelong readers were kids who were able to choose the books they wanted to read,” Burren said. “They had this steady diet of choice.” Research shows that when students have regular exposure to reading choices, they are more accepting of required reading assignments.

“What we also see with student choice is that students are reading more, and that’s the goal, right?” said Burren. “When students are reading often, they are exercising their reading muscle, and because they are reading what they like, they can get through those more complex texts. And that’s what we want to see,” said Burren.

One common barrier Burren mentioned is hesitancy on the part of teachers to have a classroom library containing books they haven’t read. “Teachers are apprehensive because they think they need to have read all the books in their classroom library to encourage students to read independently, and that’s just not the case,” Burren said.

Teachers don’t need to have read a book to ask students questions about it. A good teacher can tell a fake read from an actual read. “If we ask the right questions, we can assess whether or not students are reading.”

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More